🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Some experts said the demand for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the service has removed problematic content and banned associated keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, messages show dark colored parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.